An unusual form of BRAF-V600E mutated hairy cell neoplasm with clinical resistance to BRAF inhibition: Challenging precision medicine.

Andrea MarraAlessia SantiAlessandra PucciariniAlessandra VenanziLuca De CarolisFrancesco ZajaStefano AscaniVincenzo CanzonieriStelvio BallantiBrunangelo FaliniEnrico Tiacci

Published in: American journal of hematology (2024)

Distinct outcomes of BRAF inhibition in BRAF-mutated hairy cell neoplasms with wild-type or mutant TP53, and alternative strategies to overcome mutant TP53.

Keyphrases

wild type
single cell
cell therapy
type diabetes
stem cells
low grade
skeletal muscle
mesenchymal stem cells
glycemic control